1. Korean Neurological Association. Textbook of Neurology. 2nd ed. Seoul: Panmun Education; 2012. p. 548-52.
3. Granerod J, Crowcroft NS. The epidemiology of acute encephalitis. Neuropsychol Rehabil 2007;17:406-28.
4. Whitley RJ. Herpes simplex encephalitis: adolescents and adults. Antiviral Res 2006;71:141-8.
5. Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, et al. Viral meningoencephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 2010;17:999-e57.
6. Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, et al. Viral encephalitis: a review of diagnostic methods and guidelines for management. Eur J Neurol 2005;12:331-43.
7. DeBiasi RL, Tyler KL. Viral meningitis and encephalitis. Continuum: Lifelong Learning in Neurology 2006;12:58-94.
8. Lee KW. Textbook of Neurology. 2nd ed. Seoul: Panmun Education; 2005. p. 430-7.
9. Aslanzadeh J. Preventing PCR amplification carryover contamination in a clinical laboratory. Ann Clin Lab Sci 2004;34:389-96.
10. Kim OJ. Acute Viral Encehalitis. J Neurocrit Care 2008;1 Suppl 1:S69-S77.
11. Nahmias AJ, Whitley RJ, Visintine AN, Takei Y, Alford CA Jr. Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis 1982;145:829-36.
12. Whitley RJ, Soong SJ, Linneman C Jr, Liu C, Pazin G, Alford CA. Herpes simplex encephalitis. Clinical Assessment. JAMA 1982;247:317-20.
13. Glaser CA, Honarmand S, Anderson LJ, Schnurr DP, Forghani B, Cossen CK, et al. Beyond viruses: clinical profiles and etiologies associated with encephalitis. Clin Infect Dis 2006;43:1565-77.
14. Aslanzadeh J, Garner JG, Feder HM, Ryan RW. Use of polymerase chain reaction for laboratory diagnosis of herpes simplex virus encephalitis. Ann Clin Lab Sci 1993;23:196-202.
15. Weil AA, Glaser CA, Amad Z, Forghani B. Patients with suspected herpes simplex encephalitis: rethinking an initial negative polymerase chain reaction result. Clin Infect Dis 2002;34:1154-7.
16. Lakeman FD, Whitley RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1995;171:857-63.
18. Sawlani V. Diffusion-weighted imaging and apparent diffusion coefficient evaluation of herpes simplex encephalitis and Japanese encephalitis. J Neurol Sci 2009;287:221-6.
19. Tajima Y, Isonishi K, Kashiwaba T, Tashiro K. [Serial MRI, SPECT and 1H-MRS findings in a case of herpes simplex encephalitis]. No To Shinkei 1998;50:1023-7.
20. Whitley RJ, Alford CA, Hirsch MS, Schooley RT, Luby JP, Aoki FY, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med 1986;314:144-9.
21. Solomon T, Michael BD, Smith PE, Sanderson F, Davies NW, Hart IJ, et al. Management of suspected viral encephalitis in adults--Association of British Neurologists and British Infection Association National Guidelines. J Infect 2012;64:347-73.
22. Sawyer MH, Webb DE, Balow JE, Straus SE. Acyclovirinduced renal failure. Clinical course and histology. Am J Med 1988;84:1067-71.
23. Yan HJ. Herpes simplex encephalitis: the role of surgical decompression. Surg Neurol 2002;57:20-4.
24. Hackanson B, Zeiser R, Bley TA, Pantazis G, Huzly D, Bertz H, et al. Fatal varicella zoster virus encephalitis in two patients following allogeneic hematopoietic stem cell transplantation. Clin Transplant 2005;19:566-70.
25. De Broucker T, Mailles A, Chabrier S, Morand P, Stahl JP, steering c, et al. Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect 2012;18:808-19.
28. Persson A, Bergstrom T, Lindh M, Namvar L, Studahl M. Varicella-zoster virus CNS disease--viral load, clinical manifestations and sequels. J Clin Virol 2009;46:249-53.
29. Nagel MA, Forghani B, Mahalingam R, Wellish MC, Cohrs RJ, Russman AN, et al. The value of detecting anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology 2007;68:1069-73.
30. Arribas JR, Storch GA, Clifford DB, Tselis AC. Cytomegalovirus encephalitis. Ann Intern Med 1996;125:577-87.
31. Griffiths P. Cytomegalovirus infection of the central nervous system. Herpes: the journal of the IHMF 2004;11:95A-104A.
33. Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol 2010;9:1097-105.
34. Kim KW, Ahn SW, Park KY, Youn YC, Shin HW. Enteroviral encephalitis presenting as rapidly progressive aphasia. J Neurol Sci 2012;319:156-7.
37. Gould EA, Solomon T. Pathogenic flaviviruses. Lancet 2008;371:500-9.
38. Centers for Disease C, Prevention. West nile virus disease and other arboviral diseases - United States, 2011. MMWR Morb Mortal Wkly Rep 2012;61:510-4.
39. Sejvar JJ, Haddad MB, Tierney BC, Campbell GL, Marfin AA, Van Gerpen JA, et al. Neurologic manifestations and outcome of West Nile virus infection. JAMA 2003;290:511-5.
40. Nash D, Mostashari F, Fine A, Miller J, O’Leary D, Murray K, et al. The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med 2001;344:1807-14.
41. Burton JM, Kern RZ, Halliday W, Mikulis D, Brunton J, Fearon M, et al. Neurological manifestations of West Nile virus infection. Can J Neurol Sci 2004;31:185-93.
42. Brilla R, Block M, Geremia G, Wichter M. Clinical and neuroradiologic features of 39 consecutive cases of West Nile Virus meningoencephalitis. J Neurol Sci 2004;220:37-40.
43. Handique SK. Viral infections of the central nervous system. Neuroimaging Clin N Am 2011 21:777-94. vii.
45. Kalita J, Das BK, Misra UK. SPECT studies of regional cerebral blood flow in 8 patients with Japanese encephalitis in subacute and chronic stage. Acta Neurol Scand 1999;99:213-8.
46. Dutta K, Nazmi A, Basu A. Chemotherapy in Japanese encephalitis: are we there yet? Infect Disord Drug Targets 2011;11:300-14.
48. Ekstrand JJ, Herbener A, Rawlings J, Turney B, Ampofo K, Korgenski EK, et al. Heightened neurologic complications in children with pandemic H1N1 influenza. Ann Neurol 2010;68:762-6.
50. Glaser CA, Winter K, DuBray K, Harriman K, Uyeki TM, Sejvar J, et al. A population-based study of neurologic manifestations of severe influenza A (H1N1) pdm09 in California. Clinical Infectious Diseases 2012;55:514-20.
51. Yoshikawa H, Yamazaki S, Watanabe T, Abe T. Study of influenza-associated encephalitis/encephalopathy in children during the 1997 to 2001 influenza seasons. J Child Neurol 2001;16:885-90.
53. Kuperan S, Ostrow P, Landi MK, Bakshi R. Acute hemorrhagic leukoencephalitis vs ADEM: FLAIR MRI and neuropathology findings. Neurology 2003;60:721-2.
54. Odaka M, Yuki N, Yamada M, Koga M, Takemi T, Hirata K, et al. Bickerstaff’s brainstem encephalitis: clinical features of 62 cases and a subgroup associated with Guillain–Barré syndrome. Brain 2003;126:2279-90.
55. Sonneville R, Demeret S, Klein I, Bouadma L, Mourvillier B, Audibert J, et al. Acute disseminated encephalomyelitisin the intensive care unit: clinical features and outcome of 20 adults. Intensive Care Medicine 2008;34:528-32.
56. Sahlas DJ, Miller SP, Guerin M, Veilleux M, Francis G. Treatment of acute disseminated encephalomyelitis with intravenous immunoglobulin. Neurology 2000;54:1370-2.
57. Khurana DS, Melvin JJ, Kothare SV, Valencia I, Hardison HH, Yum S, et al. Acute disseminated encephalomyelitis in children: discordant neurologic and neuroimaging abnormalities and response to plasmapheresis. Pediatrics 2005;116:431-6.
58. Tunkel AR, Glaser CA, Bloch KC, Sejvar JJ, Marra CM, Roos KL, et al. The management of encephalitis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 2008;47:303-27.